RTW Biotech Opportunities (LSE:RTW) Short Percentage of Float


LSE:RTW RTW Biotech Opportunities Ltd LSE:RTW
36 GF Score
Price $2.33
! 2 Warning Signs
View Full Analysis

What is RTW Biotech Opportunities Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSE:RTW vs BLK, BX, KKR: Short Percentage of Float Comparison

For the Asset Management subindustry, RTW Biotech Opportunities's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RTW Biotech Opportunities Short Percentage of Float vs Asset Management Industry

For the Asset Management industry and Financial Services sector, RTW Biotech Opportunities's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where RTW Biotech Opportunities's Short Percentage of Float falls into.


LSE:RTW
36GF Score
RTW Biotech Opportunities Ltd LSE:RTW
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RTW Biotech Opportunities Business Description

Address St Julian’s Avenue, 1st Floor, Royal Chambers, St Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
36GF Score

Get the complete analysis for LSE:RTW

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.33
Price